Independent modes of natural killing distinguished in mice lacking Lag3

Science
T MiyazakiD Mathis

Abstract

The LAG3 protein has several features in common with CD4, suggesting that it may be important in controlling T cell reactivity. However, mice with a Lag3 null mutation have now been shown to exhibit a defect in the natural killer cell, rather than the T cell, compartment. Killing of certain tumor targets by natural killer cells from these mice was inhibited or even abolished, whereas lysis of cells displaying major histocompatibility complex class I disparities remained intact. It appears that LAG3 is a receptor or coreceptor that defines different modes of natural killing.

References

Jan 1, 1992·Annual Review of Immunology·Y Y YuM Bennett
May 1, 1990·The Journal of Experimental Medicine·F TriebelT Hercend
Jul 1, 1990·Immunology Today·H G Ljunggren, K Kärre
May 11, 1988·Nucleic Acids Research·B C ByrneB J Poiesz
May 1, 1995·The Journal of Experimental Medicine·F M KarlhoferW M Yokoyama
May 1, 1995·The Journal of Experimental Medicine·J C RyanW E Seaman
Apr 11, 1995·Proceedings of the National Academy of Sciences of the United States of America·W M Yokoyama
Feb 1, 1995·Current Opinion in Immunology·W M Yokoyama
Jul 5, 1994·Proceedings of the National Academy of Sciences of the United States of America·H G LjunggrenS Tonegawa
Aug 1, 1994·The Journal of Experimental Medicine·G Trinchieri

❮ Previous
Next ❯

Citations

Dec 18, 2012·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Ana StojanovicAdelheid Cerwenka
May 1, 1997·Developmental and Comparative Immunology·E C McKinney, M C Schmale
Jul 10, 1998·Immunology Letters·B HuardF Triebel
Jun 1, 1997·Current Opinion in Immunology·E O Long, N Wagtmann
Aug 26, 1998·The Journal of Experimental Medicine·T Miyazaki, F A Lemonnier
Feb 9, 2011·The Journal of Experimental Medicine·Taku OkazakiTasuku Honjo
Nov 3, 2009·International Immunology·Kirsten RichterAnnette Oxenius
Feb 1, 1997·Immunological Reviews·P HöglundK Kärre
May 27, 1997·Proceedings of the National Academy of Sciences of the United States of America·B HuardF Triebel
Mar 7, 2002·International Reviews of Immunology·K S Campbell, M Colonna
Dec 15, 2010·Expert Opinion on Therapeutic Targets·Sophie SierroDaniel E Speiser
Feb 12, 1998·The Journal of Experimental Medicine·K M BrumbaughP J Leibson
Jun 23, 2005·European Journal of Immunology·Malgorzata KisielowKlaus Karjalainen
May 19, 2010·Animal Genetics·X LuQ Zhang
Apr 15, 2010·European Journal of Immunology·Seng-Ryong WooDario A A Vignali
Sep 9, 2015·Frontiers in Immunology·Isabelle Le MercierRandolph J Noelle
Oct 16, 2004·Immunity·Ching-Tai HuangDario A A Vignali
Sep 1, 2016·Immunology and Cell Biology·Eoin F McKinney, Kenneth Gc Smith
Mar 5, 2017·Immunological Reviews·Elizabeth C NowakRandolph J Noelle
Oct 13, 2017·International Journal of Molecular Sciences·Asma Beldi-Ferchiou, Sophie Caillat-Zucman
Apr 27, 2019·Annals of the New York Academy of Sciences·Tijana Martinov, Brian T Fife
Sep 4, 2019·The Journal of Clinical Investigation·Jonathan J HodginsMichele Ardolino
Sep 5, 2008·Current Protocols in Cytometry·C C Chini, P J Leibson
Apr 16, 2020·Cancers·Lizeth G Meza GuzmanSandra E Nicholson
Jul 10, 2020·Cancers·Sachin Kumar Singh ChauhanStephan Kloess
Apr 22, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Bitao LiangRaphael Clynes
Dec 4, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Christine VogtenhuberBruce R Blazar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.